These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23825568)

  • 1. Dietary Supplement Use and Colorectal Adenoma Risk in Individuals with Lynch Syndrome: The GEOLynch Cohort Study.
    Heine-Bröring RC; Winkels RM; Botma A; van Duijnhoven FJ; Jung AY; Kleibeuker JH; Nagengast FM; Vasen HF; Kampman E
    PLoS One; 2013; 8(6):e66819. PubMed ID: 23825568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary patterns and colorectal adenomas in Lynch syndrome: the GEOLynch cohort study.
    Botma A; Vasen HF; van Duijnhoven FJ; Kleibeuker JH; Nagengast FM; Kampman E
    Cancer; 2013 Feb; 119(3):512-21. PubMed ID: 23254892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary supplement use is not associated with recurrence of colorectal adenomas: a prospective cohort study.
    Heine-Bröring RC; Winkels RM; Botma A; Wahab PJ; Tan AC; Nagengast FM; Witteman BJ; Kampman E
    Int J Cancer; 2013 Feb; 132(3):666-75. PubMed ID: 22623069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Body mass index increases risk of colorectal adenomas in men with Lynch syndrome: the GEOLynch cohort study.
    Botma A; Nagengast FM; Braem MG; Hendriks JC; Kleibeuker JH; Vasen HF; Kampman E
    J Clin Oncol; 2010 Oct; 28(28):4346-53. PubMed ID: 20733131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory potential of the diet and colorectal tumor risk in persons with Lynch syndrome.
    Brouwer JG; Makama M; van Woudenbergh GJ; Vasen HF; Nagengast FM; Kleibeuker JH; Kampman E; van Duijnhoven FJ
    Am J Clin Nutr; 2017 Nov; 106(5):1287-1294. PubMed ID: 28931533
    [No Abstract]   [Full Text] [Related]  

  • 6. Smoking increases the risk for colorectal adenomas in patients with Lynch syndrome.
    Winkels RM; Botma A; Van Duijnhoven FJ; Nagengast FM; Kleibeuker JH; Vasen HF; Kampman E
    Gastroenterology; 2012 Feb; 142(2):241-7. PubMed ID: 22062356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multivitamin, calcium and folic acid supplements and the risk of colorectal cancer in Lynch syndrome.
    Chau R; Dashti SG; Ait Ouakrim D; Buchanan DD; Clendenning M; Rosty C; Winship IM; Young JP; Giles GG; Macrae FA; Boussioutas A; Parry S; Figueiredo JC; Levine AJ; Ahnen DJ; Casey G; Haile RW; Gallinger S; Le Marchand L; Thibodeau SN; Lindor NM; Newcomb PA; Potter JD; Baron JA; Hopper JL; Jenkins MA; Win AK
    Int J Epidemiol; 2016 Jun; 45(3):940-53. PubMed ID: 27063605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary B vitamin and methionine intake and MTHFR C677T genotype on risk of colorectal tumors in Lynch syndrome: the GEOLynch cohort study.
    Jung AY; van Duijnhoven FJ; Nagengast FM; Botma A; Heine-Bröring RC; Kleibeuker JH; Vasen HF; Harryvan JL; Winkels RM; Kampman E
    Cancer Causes Control; 2014 Sep; 25(9):1119-29. PubMed ID: 24916333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of Pathogenic Variants in MLH1, MSH2, and MSH6 With Risk of Colorectal Adenomas and Tumors and With Somatic Mutations in Patients With Lynch Syndrome.
    Engel C; Ahadova A; Seppälä TT; Aretz S; Bigirwamungu-Bargeman M; Bläker H; Bucksch K; Büttner R; de Vos Tot Nederveen Cappel WT; Endris V; Holinski-Feder E; Holzapfel S; Hüneburg R; Jacobs MAJM; Koornstra JJ; Langers AM; Lepistö A; Morak M; Möslein G; Peltomäki P; Pylvänäinen K; Rahner N; Renkonen-Sinisalo L; Schulmann K; Steinke-Lange V; Stenzinger A; Strassburg CP; van de Meeberg PC; van Kouwen M; van Leerdam M; Vangala DB; Vecht J; Verhulst ML; von Knebel Doeberitz M; Weitz J; Zachariae S; Loeffler M; Mecklin JP; Kloor M; Vasen HF; ;
    Gastroenterology; 2020 Apr; 158(5):1326-1333. PubMed ID: 31926173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smoking and colorectal cancer in Lynch syndrome: results from the Colon Cancer Family Registry and the University of Texas M.D. Anderson Cancer Center.
    Pande M; Lynch PM; Hopper JL; Jenkins MA; Gallinger S; Haile RW; LeMarchand L; Lindor NM; Campbell PT; Newcomb PA; Potter JD; Baron JA; Frazier ML; Amos CI
    Clin Cancer Res; 2010 Feb; 16(4):1331-9. PubMed ID: 20145170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Routine Molecular Analysis for Lynch Syndrome Among Adenomas or Colorectal Cancer Within a National Screening Program.
    Goverde A; Wagner A; Bruno MJ; Hofstra RMW; Doukas M; van der Weiden MM; Dubbink HJ; Dinjens WNM; Spaander MCW
    Gastroenterology; 2018 Nov; 155(5):1410-1415. PubMed ID: 30063919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal cancer surveillance in Portuguese families with lynch syndrome: a cohort study.
    Vale Rodrigues R; Claro I; Lage P; Rosa I; Ferreira S; Pereira da Silva J; Dias Pereira A
    Int J Colorectal Dis; 2018 Jun; 33(6):695-702. PubMed ID: 29523990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome.
    Ait Ouakrim D; Dashti SG; Chau R; Buchanan DD; Clendenning M; Rosty C; Winship IM; Young JP; Giles GG; Leggett B; Macrae FA; Ahnen DJ; Casey G; Gallinger S; Haile RW; Le Marchand L; Thibodeau SN; Lindor NM; Newcomb PA; Potter JD; Baron JA; Hopper JL; Jenkins MA; Win AK
    J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26109217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome.
    Win AK; Lindor NM; Young JP; Macrae FA; Young GP; Williamson E; Parry S; Goldblatt J; Lipton L; Winship I; Leggett B; Tucker KM; Giles GG; Buchanan DD; Clendenning M; Rosty C; Arnold J; Levine AJ; Haile RW; Gallinger S; Le Marchand L; Newcomb PA; Hopper JL; Jenkins MA
    J Natl Cancer Inst; 2012 Sep; 104(18):1363-72. PubMed ID: 22933731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic mutations of the coding microsatellites within the beta-2-microglobulin gene in mismatch repair-deficient colorectal cancers and adenomas.
    Clendenning M; Huang A; Jayasekara H; Lorans M; Preston S; O'Callaghan N; Pope BJ; Macrae FA; Winship IM; Milne RL; Giles GG; English DR; Hopper JL; Win AK; Jenkins MA; Southey MC; Rosty C; Buchanan DD;
    Fam Cancer; 2018 Jan; 17(1):91-100. PubMed ID: 28616688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 2 diabetes mellitus, blood cholesterol, triglyceride and colorectal cancer risk in Lynch syndrome.
    Dashti SG; Li WY; Buchanan DD; Clendenning M; Rosty C; Winship IM; Macrae FA; Giles GG; Hardikar S; Hua X; Thibodeau SN; Figueiredo JC; Casey G; Haile RW; Gallinger S; Le Marchand L; Newcomb PA; Potter JD; Lindor NM; Hopper JL; Jenkins MA; Win AK
    Br J Cancer; 2019 Nov; 121(10):869-876. PubMed ID: 31551580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer spectrum in DNA mismatch repair gene mutation carriers: results from a hospital based Lynch syndrome registry.
    Pande M; Wei C; Chen J; Amos CI; Lynch PM; Lu KH; Lucio LA; Boyd-Rogers SG; Bannon SA; Mork ME; Frazier ML
    Fam Cancer; 2012 Sep; 11(3):441-7. PubMed ID: 22714864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of Lynch syndrome in consecutive patients with colorectal cancer.
    Green RC; Parfrey PS; Woods MO; Younghusband HB
    J Natl Cancer Inst; 2009 Mar; 101(5):331-40. PubMed ID: 19244167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three molecular pathways model colorectal carcinogenesis in Lynch syndrome.
    Ahadova A; Gallon R; Gebert J; Ballhausen A; Endris V; Kirchner M; Stenzinger A; Burn J; von Knebel Doeberitz M; Bläker H; Kloor M
    Int J Cancer; 2018 Jul; 143(1):139-150. PubMed ID: 29424427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Commentary on "Risks of primary extracolonic cancers following colorectal cancer in Lynch syndrome." Win AK, Lindor NM, Young JP, Macrae FA, Young GP, Williamson E, Parry S, Goldblatt J, Lipton L, Winship I, Leggett B, Tucker KM, Giles GG, Buchanan DD, Clendenning M, Rosty C, Arnold J, Levine AJ, Haile RW, Gallinger S, Le Marchand L, Newcomb PA, Hopper JL, Jenkins MA, Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, Melbourne School of Population Health, The University of Melbourne, Victoria, Australia: J Natl Cancer Inst 2012;104(18):1363-72 [Epub 2012 Aug 28].
    See WA
    Urol Oncol; 2013 Jul; 31(5):716. PubMed ID: 23796201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.